{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:58:20Z","timestamp":1788325100143,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T00:00:00Z","timestamp":1392940800000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry & Biology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.chembiol.2012.11.012","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T14:52:04Z","timestamp":1361458324000},"page":"202-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Directed Evolution of a Soluble Human IL-17A Receptor for the Inhibition of Psoriasis Plaque Formation in a Mouse Model"],"prefix":"10.1016","volume":"20","author":[{"given":"Marianna","family":"Zaretsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Etzyoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liora","family":"Sklair-Tavron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Aharoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2012.11.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib2","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T\u00a0cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2012.11.012_bib3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1073\/pnas.2536901100","article-title":"Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization","volume":"101","author":"Aharoni","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2012.11.012_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.chembiol.2005.09.012","article-title":"High-throughput screening of enzyme libraries: thiolactonases evolved by fluorescence-activated sorting of single cells in emulsion compartments","volume":"12","author":"Aharoni","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jmb.2011.12.013","article-title":"The transition of human estrogen sulfotransferase from generalist to specialist using directed enzyme evolution","volume":"416","author":"Amar","year":"2012","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib6","doi-asserted-by":"crossref","first-page":"e26794","DOI":"10.1371\/journal.pone.0026794","article-title":"The molecular basis for the broad substrate specificity of human sulfotransferase 1A1","volume":"6","author":"Berger","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.chembiol.2012.11.012_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jmb.2008.04.024","article-title":"Intense neutral drifts yield robust and evolvable consensus proteins","volume":"379","author":"Bershtein","year":"2008","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.sbi.2005.06.004","article-title":"Evolving strategies for enzyme engineering","volume":"15","author":"Bloom","year":"2005","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib9","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1073\/pnas.0510098103","article-title":"Protein\u00a0stability promotes evolvability","volume":"103","author":"Bloom","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2012.11.012_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nprot.2006.94","article-title":"Isolating and engineering human antibodies using yeast surface display","volume":"1","author":"Chao","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2012.11.012_bib11","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1093\/nar\/30.2.e9","article-title":"High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells","volume":"30","author":"Durocher","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2012.11.012_bib12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni.1813","article-title":"Structural basis of receptor sharing by interleukin 17 cytokines","volume":"10","author":"Ely","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib13","doi-asserted-by":"crossref","first-page":"e1000507","DOI":"10.1371\/journal.pbio.1000507","article-title":"Subtle alterations in PCNA-partner interactions severely impair DNA replication and repair","volume":"8","author":"Fridman","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.sbi.2007.08.012","article-title":"Yeast surface display for protein engineering and characterization","volume":"17","author":"Gai","year":"2007","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jmb.2009.10.008","article-title":"Structure of IL-17A in complex with a potent, fully human neutralizing antibody","volume":"394","author":"Gerhardt","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.copbio.2008.10.001","article-title":"Molecular decoys: antidotes, therapeutics and immunomodulators","volume":"19","author":"Gershoni","year":"2008","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1523-1747.2002.01812.x","article-title":"Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors","volume":"119","author":"Gilhar","year":"2002","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/protein\/gzm014","article-title":"Incorporating Synthetic Oligonucleotides via Gene Reassembly (ISOR): a versatile tool for generating targeted libraries","volume":"20","author":"Herman","year":"2007","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.chembiol.2012.11.012_bib20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.copbio.2009.10.010","article-title":"Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology","volume":"20","author":"Huang","year":"2009","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib21","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","article-title":"The IL-23\/IL-17 axis in inflammation","volume":"116","author":"Iwakura","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chembiol.2012.11.012_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.chembiol.2012.11.012_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrd2805","article-title":"Averting inflammation by targeting the cytokine environment","volume":"9","author":"Kopf","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2012.11.012_bib24","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.4049\/jimmunol.179.10.6379","article-title":"Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor","volume":"179","author":"Kramer","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjp.0704063","article-title":"IL-17-induced cytokine release in human bronchial epithelial cells in\u00a0vitro: role of mitogen-activated protein (MAP) kinases","volume":"133","author":"Laan","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0958-1669(00)00229-9","article-title":"Engineering proteins for thermostability: the use of sequence alignments versus rational design and directed evolution","volume":"12","author":"Lehmann","year":"2001","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib27","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2012.11.012_bib28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.copbio.2010.08.011","article-title":"Beyond directed evolution\u2014semi-rational protein engineering and design","volume":"21","author":"Lutz","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib29","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists","volume":"151","author":"Mohler","year":"1993","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-4362.1975.tb00111.x","article-title":"Clinical evaluation of desoximetasone in treatment of dermatoses and psoriasis","volume":"14","author":"Nair","year":"1975","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","article-title":"Antigen-specific T\u00a0cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses","volume":"17","author":"Nakae","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.chembiol.2012.11.012_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.chembiol.2012.11.012_bib33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2012.11.012_bib34","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1084\/jem.174.6.1483","article-title":"A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity","volume":"174","author":"Peppel","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chembiol.2012.11.012_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(03)01341-4","article-title":"Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells","volume":"462","author":"Prause","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib36","doi-asserted-by":"crossref","first-page":"10747","DOI":"10.1073\/pnas.91.22.10747","article-title":"DNA shuffling by random fragmentation and reassembly: in\u00a0vitro recombination for molecular evolution","volume":"91","author":"Stemmer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2012.11.012_bib37","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S1367-5931(02)00396-4","article-title":"Milestones in directed enzyme evolution","volume":"6","author":"Tao","year":"2002","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.sbi.2009.08.003","article-title":"Stability effects of mutations and protein evolvability","volume":"19","author":"Tokuriki","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/bies.20198","article-title":"Post-translational modifications influence transcription factor activity: a view from the ETS superfamily","volume":"27","author":"Tootle","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.chembiol.2012.11.012_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a heteromeric receptor complex","volume":"177","author":"Toy","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib41","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1742-4658.2010.07627.x","article-title":"Protein-protein interactions and selection: generation of molecule-binding proteins on the basis of tertiary structural information","volume":"277","author":"Umetsu","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.chembiol.2012.11.012_bib42","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","article-title":"The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex","volume":"181","author":"Wright","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chembiol.2012.11.012_bib43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1006\/cyto.1997.0240","article-title":"Molecular characterization of the human interleukin (IL)-17 receptor","volume":"9","author":"Yao","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.chembiol.2012.11.012_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1006\/jmbi.1996.0049","article-title":"An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues","volume":"255","author":"Zaccolo","year":"1996","journal-title":"J.\u00a0Mol. Biol."}],"container-title":["Chemistry & Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552112004656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552112004656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:19:35Z","timestamp":1761031175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074552112004656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1074552112004656"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2012.11.012","relation":{},"ISSN":["1074-5521"],"issn-type":[{"value":"1074-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Directed Evolution of a Soluble Human IL-17A Receptor for the Inhibition of Psoriasis Plaque Formation in a Mouse Model","name":"articletitle","label":"Article Title"},{"value":"Chemistry & Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2012.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}